absoricald-hcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: | ||
Meta Tags
| Title | Severe Nodular Acne Treatment | ABSORICA LD™ |
| Description | THE ABSORICA LD™ Learn about ABSORICA LD™ a severe recalcitrant nodular acne treatment. See full prescribing information, including boxed warning, and medication |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.131.86.177 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
absoricald-hcp.com Valuation
|
US$5,276,478
Last updated: 2023-05-07 11:26:50
absoricald-hcp.com has Semrush global rank of 2,005,941. absoricald-hcp.com has an estimated worth of US$ 5,276,478, based on its estimated Ads revenue. absoricald-hcp.com receives approximately 608,825 unique visitors each day. Its web server is located in United States, with IP address 104.131.86.177. According to SiteAdvisor, absoricald-hcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,276,478 |
| Daily Ads Revenue | US$4,871 |
| Monthly Ads Revenue | US$146,118 |
| Yearly Ads Revenue | US$1,753,415 |
| Daily Unique Visitors | 40,589 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| absoricald-hcp.com. | A | 599 | IP: 104.131.86.177 |
| absoricald-hcp.com. | NS | 3600 | NS Record: ns22.domaincontrol.com. |
| absoricald-hcp.com. | NS | 3600 | NS Record: ns21.domaincontrol.com. |
HtmlToTextCheckTime:2023-05-07 11:26:50
| RELAPSE RATES ABSORPTION MICRONIZATION DOSING SUPPORT Important Safety Information Prescribing Information Medication Guide iPLEDGE ® Contact Patient Site Pharmacy Finder THE ABSORICA LD™ DIFFERENCE For the treatment of severe recalcitrant nodular acne Give your patients the chance for complete and prolonged remission 1,2 IMPORTANT SAFETY INFORMATION Because of the risk of embryo-fetal toxicity, ABSORICA LD is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the iPLEDGE ® REMS. Please see full Important Safety Information. NOT ACTUAL PATIENT NOT ACTUAL PATIENT Low relapse & retreatment rates 1,2 2X more absorption 2,3 Compared to ABSORICA ® * (isotretinoin) in a fasted state Innovative micronized formulation 2,4 Dosing for greater therapeutic serum levels *ABSORICA ® /ABSORICA LD™ Clinical Statement The effectiveness of ABSORICA/ABSORICA LD for the treatment of severe recalcitrant nodular acne in patients 12 years of age and |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Wed, 27 Oct 2021 22:33:42 GMT Server: Apache/2.4.41 (Ubuntu) Location: https://absoricald-hcp.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Wed, 27 Oct 2021 22:33:42 GMT Server: Apache/2.4.41 (Ubuntu) Last-Modified: Fri, 15 Oct 2021 13:12:39 GMT ETag: "622b7-5ce63f31af4c3" Accept-Ranges: bytes Content-Length: 402103 Vary: Accept-Encoding Content-Type: text/html |
absoricald-hcp.com Whois Information
Domain Name: ABSORICALD-HCP.COM Registry Domain ID: 2454493063_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-04-01T03:27:37Z Creation Date: 2019-11-12T22:18:06Z Registry Expiry Date: 2022-11-12T22:18:06Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS21.DOMAINCONTROL.COM Name Server: NS22.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T17:46:06Z <<< |